MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 7.17 USD 0.14% Market Closed
Market Cap: 1.1B USD

Intrinsic Value

The intrinsic value of one MDXG stock under the Base Case scenario is 6.77 USD. Compared to the current market price of 7.17 USD, MiMedx Group Inc is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDXG Intrinsic Value
6.77 USD
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
MiMedx Group Inc

MDXG
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MDXG cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

MiMedx Group Inc
NASDAQ:MDXG
US
Biotechnology
Market Cap
1.1B USD
IPO
Aug 20, 2007
US
Biotechnology
Market Cap
1.1B USD
IPO
Aug 20, 2007
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about MiMedx Group Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
MiMedx Group Inc

Current Assets 200.1m
Cash & Short-Term Investments 106.4m
Receivables 62.3m
Other Current Assets 31.4m
Non-Current Assets 70.3m
PP&E 11.1m
Intangibles 30.5m
Other Non-Current Assets 28.7m
Efficiency

Free Cash Flow Analysis
MiMedx Group Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
MiMedx Group Inc

Revenue
352.4m USD
Cost of Revenue
-63.6m USD
Gross Profit
288.7m USD
Operating Expenses
-243.4m USD
Operating Income
45.3m USD
Other Expenses
-5.1m USD
Net Income
40.2m USD
Fundamental Scores

MDXG Profitability Score
Profitability Due Diligence

MiMedx Group Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

61/100
Profitability
Score

MiMedx Group Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

MDXG Solvency Score
Solvency Due Diligence

MiMedx Group Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Negative Net Debt
99/100
Solvency
Score

MiMedx Group Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDXG Price Targets Summary
MiMedx Group Inc

Wall Street analysts forecast MDXG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDXG is 12.24 USD with a low forecast of 11.11 USD and a high forecast of 13.65 USD.

Lowest
Price Target
11.11 USD
55% Upside
Average
Price Target
12.24 USD
71% Upside
Highest
Price Target
13.65 USD
90% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

MiMedx Group Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MDXG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MDXG Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MDXG stock?

The intrinsic value of one MDXG stock under the Base Case scenario is 6.77 USD.

Is MDXG stock undervalued or overvalued?

Compared to the current market price of 7.17 USD, MiMedx Group Inc is Overvalued by 6%.

Back to Top